The effect of natalizumab treatment on cytokine profiles and clinical outcome measures in multiple sclerosis

被引：0
|
作者：
Khademi, Mohsen [1 ]
Rafatnia, Farshid [1 ]
Andersson, Magnus [2 ]
Brundin, Lou [2 ]
Wallstroem, Erik [3 ]
Piehl, Fredrik [1 ]
Olsson, Tomas [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Karoliska Univ Hosp, Stockholm, Sweden
[3] Novartis, Basel, Switzerland
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2008年 / 203卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [1] The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis
    Mustafa, Wessam
    Elgendy, Nadia
    Salama, Samer
    Jawad, Mohamed
    Eltoukhy, Khaled
    MULTIPLE SCLEROSIS INTERNATIONAL, 2021, 2021
  • [2] Natalizumab Treatment for Multiple Sclerosis in Clinical Practice
    Thyerlei, Dinah
    Hillman, Lynda
    Woolvett, Valerie
    Krasucki, Dora
    Wundes, Annette
    NEUROLOGY, 2010, 74 (09) : A554 - A554
  • [3] Clinical outcome measures in multiple sclerosis
    Amato, Maria Pia
    Portaccio, Emilio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 259 (1-2) : 118 - 122
  • [4] The effectiveness of Natalizumab on MRI outcome measures in patients with relapsing multiple sclerosis
    Dalton, C
    Barker, G
    MacManus, D
    Miszkiel, K
    Bates, D
    Blumhardt, L
    Hawkins, C
    Palace, J
    Sharief, M
    Swingler, R
    Young, C
    Miller, D
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (03): : 399 - 399
  • [5] Effect of the natalizumab treatment on cererospinal fluid measures in multiple sclerosis: a longitudinal study.
    Benova, Barbora
    Andelova, Michaela
    Kadrnozkova, Lucie
    Havrdova, Eva
    Horakova, Dana
    Uher, Tomas
    NEUROLOGY, 2017, 88
  • [6] Natalizumab treatment modifies peripheral cytokine profile in multiple sclerosis patients
    Balasa, R.
    Bajko, Z.
    Hutanu, A.
    Voidazan, S.
    Maier, S. M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 607 - 607
  • [7] Clinical outcome measures for research in multiple sclerosis
    Balcer, LJ
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2001, 21 (04) : 296 - 301
  • [8] Outcome Measures in Clinical Trials for Multiple Sclerosis
    van Munster, Caspar E. P.
    Uitdehaag, Bernard M. J.
    CNS DRUGS, 2017, 31 (03) : 217 - 236
  • [9] Outcome Measures in Clinical Trials for Multiple Sclerosis
    Caspar E. P. van Munster
    Bernard M. J. Uitdehaag
    CNS Drugs, 2017, 31 : 217 - 236
  • [10] Outcome measures in multiple sclerosis clinical trials
    Andersson, PB
    Goodkin, DE
    BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 409 - 428
12345